Repligen (RGEN) EBITDA Margin (2010 - 2026)
Repligen's (RGEN) quarterly EBITDA Margin came in at 6.85% in Q2 2026, down 77.0% year-over-year from 29.77% in Q2 2025, and down 16.56% quarter-over-quarter from 8.21% in Q1 2026.
Powered by 
Analysis
Repligen (RGEN) EBITDA Margin (2010 - 2026) Analysis & Trends
Repligen (RGEN) has reported EBITDA Margin for 17 consecutive years, with 6.85% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin fell 77.0% year-over-year to 6.85% in Q2 2026; TTM through Jun 2026 was 8.23%, a 1177.0% increase from a year earlier, with the FY2025 full-year figure at 7.47%, up 1301.0% from the prior year.
- EBITDA Margin was 6.85% for Q2 2026 at Repligen, down from 8.21% in the prior quarter.
- Over five years, EBITDA Margin peaked at 30.42% in Q2 2022 and troughed at 21.79% in Q4 2024.
- A 5-year average of 9.18% and a median of 7.91% in 2025 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin plunged 2771 bps in 2024 and soared 3081 bps in 2025, its largest moves.
- Over 5 years, EBITDA Margin stood at 26.15% in 2022, then tumbled by 77 bps to 5.93% in 2023, then slumped by 468 bps to 21.79% in 2024, then jumped by 141 bps to 9.03% in 2025, then dropped by 24 bps to 6.85% in 2026.
- The last three EBITDA Margin figures came in at 6.85% (Q2 2026), 8.21% (Q1 2026), and 9.03% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.58 Bn | 219.52 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 142.63 Bn | 138.28 Bn | 3.61 Bn | 17.99% |
| 3 | Agilent Technologies | 40.41 Bn | 38.65 Bn | 1.04 Bn | 23.64% |
| 4 | Illumina | 30.70 Bn | 29.54 Bn | 770.00 Mn | 21.14% |
| 5 | Revvity | 13.62 Bn | 12.60 Bn | 416.87 Mn | 12.24% |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 23.13% |
| 7 | Bio-Rad Laboratories | 9.99 Bn | 8.38 Bn | 345.80 Mn | 11.15% |
| 8 | Repligen | 9.21 Bn | 8.19 Bn | 110.04 Mn | 6.85% |
| 9 | 10x Genomics | 8.68 Bn | 8.12 Bn | 112.50 Mn | -12.95% |
| 10 | Bruker | 8.21 Bn | 7.99 Bn | 416.00 Mn | -7.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.85% |
| Mar 31, 2026 | 8.21% |
| Dec 31, 2025 | 9.03% |
| Sep 30, 2025 | 8.91% |
| Jun 30, 2025 | 7.62% |
| Mar 31, 2025 | 3.89% |
| Dec 31, 2024 | -21.79% |
| Sep 30, 2024 | -5.06% |
| Jun 30, 2024 | 3.44% |
| Mar 31, 2024 | 2.45% |
| Dec 31, 2023 | 5.93% |
| Sep 30, 2023 | 3.32% |
| Jun 30, 2023 | 12.11% |
| Mar 31, 2023 | 8.38% |
| Dec 31, 2022 | 26.15% |
| Sep 30, 2022 | 26.24% |
| Jun 30, 2022 | 30.42% |
| Mar 31, 2022 | 29.07% |
| Dec 31, 2021 | 20.07% |
| Sep 30, 2021 | 25.36% |